Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Mar 21;294(6574):759–762. doi: 10.1136/bmj.294.6574.759

Menorrhagia.

M Rees
PMCID: PMC1245808  PMID: 3105728

Full text

PDF
762

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson A. B., Haynes P. J., Guillebaud J., Turnbull A. C. Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors. Lancet. 1976 Apr 10;1(7963):774–776. doi: 10.1016/s0140-6736(76)91612-3. [DOI] [PubMed] [Google Scholar]
  2. Chimbira T. H., Anderson A. B., Naish C., Cope E., Turnbull A. C. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo. Br J Obstet Gynaecol. 1980 Dec;87(12):1152–1158. doi: 10.1111/j.1471-0528.1980.tb04489.x. [DOI] [PubMed] [Google Scholar]
  3. Chimbira T. H., Anderson A. B., Turnbull A. c. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. Br J Obstet Gynaecol. 1980 Jul;87(7):603–609. doi: 10.1111/j.1471-0528.1980.tb05013.x. [DOI] [PubMed] [Google Scholar]
  4. Fraser I. S., McCarron G., Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol. 1984 Aug 1;149(7):788–793. doi: 10.1016/0002-9378(84)90123-6. [DOI] [PubMed] [Google Scholar]
  5. Hallberg L., Högdahl A. M., Nilsson L., Rybo G. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45(3):320–351. doi: 10.3109/00016346609158455. [DOI] [PubMed] [Google Scholar]
  6. Hare M. J. Pelvic inflammatory disease. Br Med J (Clin Res Ed) 1986 Nov 8;293(6556):1225–1228. doi: 10.1136/bmj.293.6556.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Landgren B. M., Diczfalusy E. Hormonal effects of the 300 microgram norethisterone (NET) minipill. I. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration. Contraception. 1980 Jan;21(1):87–113. doi: 10.1016/0010-7824(80)90142-0. [DOI] [PubMed] [Google Scholar]
  8. Massil H., O'Brien P. M. Premenstrual syndrome. Br Med J (Clin Res Ed) 1986 Nov 15;293(6557):1289–1292. doi: 10.1136/bmj.293.6557.1289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McMillan M., Spinks E. A., Fenwick G. R. Preliminary observations on the effect of dietary brussels sprouts on thyroid function. Hum Toxicol. 1986 Jan;5(1):15–19. doi: 10.1177/096032718600500104. [DOI] [PubMed] [Google Scholar]
  10. Rees M. C., Anderson A. B., Demers L. M., Turnbull A. C. Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea. Br J Obstet Gynaecol. 1984 Jul;91(7):673–680. doi: 10.1111/j.1471-0528.1984.tb04829.x. [DOI] [PubMed] [Google Scholar]
  11. Rybo G. Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss. Acta Obstet Gynecol Scand. 1966;45(4):429–450. doi: 10.3109/00016346609158462. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES